Unknown

Dataset Information

No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor.


ABSTRACT: The spike protein of SARS-CoV-2 is known to enable viral invasion into human cells through direct binding to host receptors including ACE2. An alternate entry receptor for the virus was recently proposed to be basigin/CD147. These early studies have already prompted a clinical trial and multiple published hypotheses speculating on the role of this host receptor in viral infection and pathogenesis. Here, we report that we are unable to find evidence supporting the role of basigin as a putative spike binding receptor. Recombinant forms of the SARS-CoV-2 spike do not interact with basigin expressed on the surface of human cells, and by using specialized assays tailored to detect receptor interactions as weak or weaker than the proposed basigin-spike binding, we report no evidence for a direct

SUBMITTER: Shilts J 

PROVIDER: S-EPMC7801465 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature